EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases

Andrea Baldo, Odysseas P Chatzipanagiotou, Jun Kawashima, Gaya Spolverato, Andrea Ruzzenente, George A Poultsides, Kazunari Sasaki, Itaru Endo, Minoru Kitago, Federico Aucejo, Irinel Popescu, Tom Hugh und 6 weitere

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.70040 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Andrea Baldo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Liver Neoplasms, Proto-Oncogene Proteins p21(ras), Hepatectomy. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the impact of surgical timing—simultaneous versus staged resection—on outcomes of patients with colorectal liver metastases (CRLM) in relation to KRAS mutation status, which is a key factor affecting prognosis.

Methods

Patients who underwent curative‐intent resection for synchronous CRLM (sCRLM) were identified from an international, multi‐institutional database. The association between clinicopathologic factors, staged versus simultaneous approach and wild‐type (wtKRAS) versus mutated (mtKRAS) KRAS with long‐term outcomes was assessed.

Results

Among 385 patients who underwent curative‐intent resection for sCRLM, 205 (53.2%) individuals underwent a simultaneous primary tumor and CRLM resection; 180 (46.8%) individuals underwent a staged surgical approach. On multivariable analysis, the staged approach remained associated with improved OS compared with the simultaneous approach among patients who had mtKRAS CRLM (HR: 0.62, 95% CI: 0.39–0.99). Patients with mtKRAS and high TBS demonstrated an improved 5‐year OS (67.0%, 95% CI: 54.2%–83.0% vs. 47.5%, 95% CI: 31.4%, 71.9%; p = 0.04) compared with a simultaneous procedure. There was no difference in OS among patients with either wtKRAS or mtKRAS and low TBS who underwent staged versus simultaneous resection ( p > 0.05).

Conclusion

Patients with sCRLM and an aggressive tumor biology as defined by KRAS status and TBS may benefit from a two‐stage resection which may improve patient selection relative to achieving better long‐term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsLiver NeoplasmsProto-Oncogene Proteins p21(ras)HepatectomyHumansMaleFemaleMiddle AgedAgedMutationPrognosisRetrospective StudiesSurvival RateAdultFollow-Up Studies

Stichwörter der Autor:innen

KRAScolorectal liver metastasesdisease‐free survivalliver surgeryoverall survivaltumor burden score

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Division of General and Hepatobiliary Surgery, University of Verona, Verona, Italy.
  • Department of Surgery, Stanford University, Stanford, California, USA.
  • Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
  • Department of Surgery, Keio University, Tokyo, Japan.

ORCID-Profile: Sepideh Gholami, Timothy M Pawlik

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Baldo, A., Chatzipanagiotou, O. P., Kawashima, J., Spolverato, G., Ruzzenente, A., Poultsides, G. A., Sasaki, K., Endo, I., Kitago, M., Aucejo, F., Popescu, I., Hugh, T., Bhimani, N., Weiss, M., Gholami, S., He, J., Aldrighetti, L., & Pawlik, T. M. (2025). The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70040

Vancouver

Baldo A, Chatzipanagiotou OP, Kawashima J, Spolverato G, Ruzzenente A, Poultsides GA, et al. The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70040

BibTeX
@article{Baldo2025,
  author = {Baldo, Andrea and Chatzipanagiotou, Odysseas P and Kawashima, Jun and Spolverato, Gaya and Ruzzenente, Andrea and Poultsides, George A and Sasaki, Kazunari and Endo, Itaru and Kitago, Minoru and Aucejo, Federico and Popescu, Irinel and Hugh, Tom and Bhimani, Nazim and Weiss, Matthew and Gholami, Sepideh and He, Jin and Aldrighetti, Luca and Pawlik, Timothy M},
  title = {The Role of KRAS Status Among Patients Undergoing Staged Versus Simultaneous Resection for Synchronous Colorectal Liver Metastases},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.70040}
}
Kostenlos starten →